Wed, Sep 17, 2014, 3:10 AM EDT - U.S. Markets open in 6 hrs 20 mins


% | $
Quotes you view appear here for quick access.

Questcor Pharmaceuticals, Inc. (QCOR) Message Board

  • sam_0534 sam_0534 Jun 11, 2013 2:27 PM Flag

    Price target raised....

    UPDATE: Questcor Pharma Soars 20% on Acquisition Rights to Synacthen, Ladenburg Boosts PT $19 06/11 10:57 AM

    01:57 PM EDT, 06/11/2013 (MidnightTrader) -- Questcor Pharmaceuticals Inc. (QCOR:$43.73,00$7.02,0019.12%) is up 19.6% to $43.89 in afternoon trade, moving on volume of 13.6 million versus the 30-day average of 1.9 million.
    The company this morning said it has acquired rights to develop Synacthen and Synacthen Depot in the U.S. from Novartis Pharma AG/Novartis AG for $135 million in addition to potential milestone payments prior to FDA approval.
    Subject to certain closing conditions, QCOR has also acquired rights to Synacthen and Synacthen Depot in certain countries outside the U.S.
    Analysts at Ladenburg Thalmann today raised their price target on QCOR to $54 from $35.
    Price: 43.89, Change: +7.18, Percent Change: +19.6

    Sentiment: Strong Buy

93.600.00(0.00%)Aug 14 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.